Anacalypsis Therapeutics is dedicated to developing innovative and effective treatments for diseases that affect the brain and nervous system. They are committed to this mission and excited about the potential impact it can have on patients’ lives. They aim to discover tje precision gene- and pathway-based disease-modifying therapeutic strategies to disrupt the progression of neurodegenerative diseases, like Parkinson’s Disease.

Anacalypsis Therapeutics is focused on developing biomarkers that can identify Parkinson’s disease at an early stage and on creating innovative treatments that can modify the disease’s course. We are currently working on advanced genetically linked targets to apply Precision Neurology, ie. provide personalized treatments that will cater to the individual needs of patients.

Team: Alexia Polissidis, PhD, Hardy Rideout , PhD.